載入...
In Vitro Assessment of Re-treatment Options for Patients with Hepatitis C Virus Genotype 1b Infection Resistant to Daclatasvir Plus Asunaprevir
INTRODUCTION: Daclatasvir is a non-structural protein 5A (NS5A) inhibitor with activity against hepatitis C virus (HCV) genotypes 1–6 in vitro, and asunaprevir is a non-structural protein 3 (NS3) protease inhibitor with activity against genotypes 1, 4, 5, and 6. This study evaluates potential option...
Na minha lista:
| 發表在: | Infect Dis Ther |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Healthcare
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4363215/ https://ncbi.nlm.nih.gov/pubmed/25516102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-014-0052-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|